Organon dedicates 'Her Day' for Women’s Health | Inquirer Business | Advertorials
Close  

Organon dedicates ‘Her Day’ for Women’s Health

/ 08:00 AM June 03, 2021

Organon & Co Inc., a global healthcare company is celebrating HER DAY today to mark the beginning of its mission to deliver innovative health solutions for Filipino women as conveyed through its tagline ‘Here for Her Health.’ 

Organon & Co Inc

Present in over 140 countries including the Philippines and with a portfolio of more than 60 medicines and products, Organon will help address a spectrum of conditions women face including reproductive health issues, heart disease, breast cancer, allergies, and asthma. 

Organon is a global healthcare company formed through a spinoff from Merck & Co., Inc. Kenilworth, N.J., U.S.A. (collectively with its affiliates “MSD”) to focus on improving the health of women throughout their lives.

FEATURED STORIES

ADVT

Read more Business stories:

Excalibur Builders keeps up with high demand for luxury homes

Avida Land delivers future-proof communities, offers best value homes in VisMin

St. Luke’s introduces advanced disease detection and cancer treatment technology

Subscribe to our business newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: global healthcare company, Her Day, Organon & Co Inc.
For feedback, complaints, or inquiries, contact us.

Subscribe to our business news

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.